Floatz logo

Lapine T-Lymphocyte Immune Globulin

Hematologic Neoplasm With Germline GATA2 Mutation

Fred Hutchinson Cancer CenterPhase 2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Hematologic Neoplasm With Germline GATA2 Mutation cohort.

Asset / SponsorPhaseRating
Treosulfan
Fred Hutchinson Cancer Center
Phase 2B
TACROLIMUS
Fred Hutchinson Cancer Center
Phase 2B
METHOTREXATE
Fred Hutchinson Cancer Center
Phase 2B
Fludarabine
Fred Hutchinson Cancer Center
Phase 2B

Same molecule, other indications

Lapine T-Lymphocyte Immune Globulin is also rated in:

bone marrow failure syndromeDormant
CCC
Indicative ·
48 / 100
View asset →
congenital amegakaryocytic thrombocytopeniaDormant
CCC
Indicative ·
48 / 100
View asset →
Diamond-Blackfan anemiaDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →